1 Live Vaccines Market Overview
1.1 Product Overview and Scope of Live Vaccines
1.2 Live Vaccines Segment by Type
1.2.1 Global Live Vaccines Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Monovalent Live Vaccines
1.2.3 Multivalent Live Vaccines
1.3 Live Vaccines Segment by Application
1.3.1 Global Live Vaccines Sales Comparison by Application: (2022-2028)
1.3.2 Adults
1.3.3 Children
1.4 Global Live Vaccines Market Size Estimates and Forecasts
1.4.1 Global Live Vaccines Revenue 2017-2028
1.4.2 Global Live Vaccines Sales 2017-2028
1.4.3 Live Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028
2 Live Vaccines Market Competition by Manufacturers
2.1 Global Live Vaccines Sales Market Share by Manufacturers (2017-2022)
2.2 Global Live Vaccines Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Live Vaccines Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Live Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Live Vaccines Market Competitive Situation and Trends
2.5.1 Live Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Live Vaccines Players Market Share by Revenue
2.5.3 Global Live Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Live Vaccines Retrospective Market Scenario by Region
3.1 Global Live Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Live Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Live Vaccines Market Facts & Figures by Country
3.3.1 North America Live Vaccines Sales by Country
3.3.2 North America Live Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Live Vaccines Market Facts & Figures by Country
3.4.1 Europe Live Vaccines Sales by Country
3.4.2 Europe Live Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Live Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Live Vaccines Sales by Region
3.5.2 Asia Pacific Live Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Live Vaccines Market Facts & Figures by Country
3.6.1 Latin America Live Vaccines Sales by Country
3.6.2 Latin America Live Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Live Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Live Vaccines Sales by Country
3.7.2 Middle East and Africa Live Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Live Vaccines Historic Market Analysis by Type
4.1 Global Live Vaccines Sales Market Share by Type (2017-2022)
4.2 Global Live Vaccines Revenue Market Share by Type (2017-2022)
4.3 Global Live Vaccines Price by Type (2017-2022)
5 Global Live Vaccines Historic Market Analysis by Application
5.1 Global Live Vaccines Sales Market Share by Application (2017-2022)
5.2 Global Live Vaccines Revenue Market Share by Application (2017-2022)
5.3 Global Live Vaccines Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck Live Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.2.4 GlaxoSmithKline Live Vaccines Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Pfizer Live Vaccines Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novartis Live Vaccines Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Astellas Pharma
6.5.1 Astellas Pharma Corporation Information
6.5.2 Astellas Pharma Description and Business Overview
6.5.3 Astellas Pharma Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Astellas Pharma Live Vaccines Product Portfolio
6.5.5 Astellas Pharma Recent Developments/Updates
6.6 Emergent BioSolutions
6.6.1 Emergent BioSolutions Corporation Information
6.6.2 Emergent BioSolutions Description and Business Overview
6.6.3 Emergent BioSolutions Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Emergent BioSolutions Live Vaccines Product Portfolio
6.6.5 Emergent BioSolutions Recent Developments/Updates
6.7 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Live Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AstraZeneca Live Vaccines Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
7 Live Vaccines Manufacturing Cost Analysis
7.1 Live Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Live Vaccines
7.4 Live Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Live Vaccines Distributors List
8.3 Live Vaccines Customers
9 Live Vaccines Market Dynamics
9.1 Live Vaccines Industry Trends
9.2 Live Vaccines Market Drivers
9.3 Live Vaccines Market Challenges
9.4 Live Vaccines Market Restraints
10 Global Market Forecast
10.1 Live Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Live Vaccines by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Live Vaccines by Type (2023-2028)
10.2 Live Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Live Vaccines by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Live Vaccines by Application (2023-2028)
10.3 Live Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Live Vaccines by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Live Vaccines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
